Company intelligence / Profile preview

Chemtrix

Geleen, Netherlands

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Chemtrix develops and supplies scalable flow chemistry reactor systems primarily for the fine chemicals and pharmaceutical industries, enabling continuous process development from small lab scale to industrial production. Their portfolio addresses the need for safe, cost-efficient, and flexible production, bridging R&D with commercial-scale manufacturing[1][2][3][4][5].

Industry: Drug Discovery Services

Partnerships

Lionix BVUniversity of HullDSMJanssen Pharmaceutica3M Technical CeramicsShenzhen E-zheng Technology Co.Perceptive EngineeringSanofi-AventisCCFLOW Consortium

Beyond the preview

Go deeper on Chemtrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chemtrix.

Explore the full profile